Personalised analytics for rare disease diagnostics
Genome sequencing is being widely adopted for diagnosis of genetic diseases, but identifying the causal variants remains challenging. Here, the authors introduce a tool that incorporates tissue-specific gene expression data into predicting variant pathogenicity, improving accuracy.
Saved in:
Main Authors: | Denise Anderson, Gareth Baynam, Jenefer M. Blackwell, Timo Lassmann |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/63acb38dd4c14d16b5884b95ac16f5b9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening
by: Lorna J. Hale, et al.
Published: (2018) -
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
by: Kartik Kumar, et al.
Published: (2021) -
Community capital and the role of the state: an empowering approach to personalisation
by: Patricia Jones
Published: (2013) -
The effect of protein mutations on drug binding suggests ensuing personalised drug selection
by: Shunzhou Wan, et al.
Published: (2021) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
by: Pascal Hendrik Pieter de Jong, et al.
Published: (2021)